Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Galajda

Showing results (71-80 of 72) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 72 results.
Pharmaceuticals (Basel, Switzerland)|September 27, 2025
Effect of Submaximal Doses of Semaglutide in Patients with Obesity on Metabolic Profile and Serum Levels of AdipocytokinesMartin Jozef Péč, Jakub Jurica, Monika Péčová, et al.
Metabolites|February 25, 2025
Endothelial Markers in Type 2 Diabetic Patients with Acute Decompensated Heart Failure: A Pilot StudyMartin Jozef Péč, Jakub Jurica, Tomáš Bolek, et al.
Pageof 8

Showing results (71-80 of 72) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 72 results.
Pharmaceuticals (Basel, Switzerland)|September 27, 2025
Effect of Submaximal Doses of Semaglutide in Patients with Obesity on Metabolic Profile and Serum Levels of AdipocytokinesMartin Jozef Péč, Jakub Jurica, Monika Péčová, et al.
Metabolites|February 25, 2025
Endothelial Markers in Type 2 Diabetic Patients with Acute Decompensated Heart Failure: A Pilot StudyMartin Jozef Péč, Jakub Jurica, Tomáš Bolek, et al.
Pageof 8